Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.

Natural history of pruritus in primary biliary cirrhosis

Talwalkar, Jayant A, Souto, Enrico, Jorgensen, Roberta A, Lindor, Keith D · 2003 · Clinical Gastroenterology and Hepatology

Abstract

The natural history of pruritus in primary biliary cirrhosis (PBC) remains poorly defined. The aim of this investigation was to evaluate outcomes of pruritus in clinical trials for ursodeoxycholic acid (UDCA). In a UDCA-placebo trial begun in 1988 (n = 180), a 55% prevalence rate for pruritus was observed. Serum alkaline phosphatase level and Mayo risk score were independent risk factors for pruritus (P < 0.0001). Among placebo-treated patients (n = 91), the annual risks for development or improvement/resolution of pruritus were 27% and 23%, respectively. For UDCA-treated patients (n = 89), a trend toward improvement in pruritus was observed after 1 year compared to placebo (30% vs. 23%, P = 0.08) but not at 2 or 3 years. In a 3-dose UDCA trial begun in 1995 (n = 155), the overall prevalence of pruritus was significantly lower at 37% when compared to UDCA-placebo participants (P < 0.001). Baseline serum alkaline phosphatase level and Mayo risk score were again independent risk factors for pruritus (P < 0.0001). Among 13 (3.9%) patients with refractory pruritus, symptom resolution (n = 5) or improvement (n = 8) was associated with the use of oral rifampin (300 or 600 mg daily). Two patients treated with rifampin developed biochemical evidence for hepatotoxicity necessitating drug withdrawal. Although less prevalent among recently diagnosed individuals, more than one third of PBC patients develop pruritus. No significant risk reduction in developing pruritus with UDCA therapy w…

Overview

Integrity signals

Registry

Crossref · 10.1016/s1542-3565(03)00134-4

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 25 references

Research works printed but not linked: 1

  1. Prince, 2000, Symptom development and prognosis of initially asymptomatic primary biliary cirrhosis (PBC), Hepatology, 32, 171A

Cited by

See all 141

Metadata

Authors
Talwalkar, J. A., Souto, E., Jorgensen, R. A., & Lindor, K. D.
Affiliations
Mayo Clinic (US)
Venue
Clinical Gastroenterology and Hepatology
Publisher
Elsevier BV
Published
2003-07
Volume
1
Issue
4
Pages
297-302
ISSN
1542-3565 (ISSN-L)
OpenAlex
W2094285893
Cited by
141
References
25
Citations by year
2026: 5 · 2025: 5 · 2024: 13 · 2023: 6 · 2022: 12 · 2021: 6 · 2020: 1 · 2019: 7 · 2018: 10 · 2017: 9 · 2016: 4 · 2015: 6 · 2014: 7 · 2013: 3 · 2012: 7
FWCI
3.00
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • Clinical Gastroenterology and Hepatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
primary biliary cirrhosis, pruritus, ursodeoxycholic acid, rifampicin, refractory pruritus, serum alkaline phosphatase, Mayo risk score, hepatotoxicity
MeSH terms
Adult, Alkaline Phosphatase, Antipruritics, Aspartate Aminotransferases, Bilirubin, Cholagogues and Choleretics, Cholestyramine Resin, Dose-Response Relationship, Drug, Double-Blind Method, Enzyme Inhibitors, Female, Follow-Up Studies, Humans, Liver Cirrhosis, Biliary, Liver Function Tests, Male, Middle Aged, Minnesota, Predictive Value of Tests, Pruritus, Rifampin, Risk Factors, Serum Albumin, Severity of Illness Index, Ursodeoxycholic Acid, Biomarkers, Incidence, Multivariate Analysis, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Natural history of pruritus in primary biliary cirrhosis. https://app.cochat.ai/papers/10.1016/s1542-3565(03)00134-4
The paper
Talwalkar, J. A., Souto, E., Jorgensen, R. A., & Lindor, K. D. (2003). Natural history of pruritus in primary biliary cirrhosis. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/s1542-3565(03)00134-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.